Is reduction in the risk of vision loss the only benefit of photodynamic therapy in predominantly classic subfoveal choroidal neovascularization?
Nicola G Ghazi, rian P Conway, James S Tiedeman, Steven J YoonUniversity of Virginia Health System, Department of Ophthalmology, Charlottesville, VA, USAPurpose: To emphasize the effect of photodynamic therapy (PDT) on the size and progression of the neovascular lesion (NL) and evolution of the disc...
Guardado en:
Autores principales: | Nicola G Ghazi, Brian P Conway, James S Tiedeman, Steven J Yoon |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/69258267454e494bb11fc5ec5b2940b9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Can macular translocation be a satisfactory management of subfoveal choroidal neovascular membrane?
por: Árpád Bereczki, et al.
Publicado: (2008) -
Subfoveal choroidal thickness in diabetic macular edema
por: Mohamed DM, et al.
Publicado: (2019) -
Submacular predominantly hemorrhagic choroidal neovascularization: resolution of bleedings under anti-VEGF therapy
por: Dimopoulos S, et al.
Publicado: (2015) -
The relationship between Subfoveal Choroidal Thickness and Hypertensive Retinopathy
por: Lei Shao, et al.
Publicado: (2021) -
Photodynamic therapy of choroidal neovascularization with enlargement of the spot size to include the feeding complex
por: Ilias Georgalas, et al.
Publicado: (2008)